TGFB1 and amyotrophic lateral sclerosis: Thus, although only a few samples were available for analysis, the results support existing evidence on a role for reduced TGFβ activity in ALS and are expected to provide a means to measure TGFβ pathway activity in brain tissue samples of ALS patients.